In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.

Zachary Grinspan, MD, pediatric neurologist and clinical lead supervising the gene therapy treatment and subsequent care of Riaan. [Gurjot "Jo" Kaur] On April 21, 2026, on the 3rd floor at the Child ...

The Public Data for Health program will assist nonprofits and universities in developing, preserving, and sharing ...

An existing anti-seizure medication may offer a way to fight diffuse midline glioma, one of the deadliest forms of childhood ...

A novel collagen-targeted MRI contrast agent detects lung cancer and metastases with greater sensitivity than traditional ...

A virtual team of AI agents modeled on the structure of a traditional drug-development company could efficiently combine ...

Researchers could simulate hypoxic damage and neuropsychiatric diseases in difficult-to-study human cells and circuits.

Researchers reveal how tumors suppress p53 neoantigen presentation and that targeting ERAP1 can restore T-cell recognition of cancer cells.

A new CRISPR screening platform has identified a gene causing lymphoma cells to become resistant to venetoclax.

In a study of kidney cancer in rats, a Japanese team found that giant-nucleus cells that survive iron-induced damage may form ...

Hemoglobin levels that place a person at borderline risk of anemia may need further investigation, as those considered within ...